<--- Back to Details
First PageDocument Content
Corporations law / Private law / Committees / Auditing / Board of directors / Company secretary / Non-executive director / Internal audit / Chief financial officer / Corporate governance / Business / Management
Date: 2010-04-19 02:02:54
Corporations law
Private law
Committees
Auditing
Board of directors
Company secretary
Non-executive director
Internal audit
Chief financial officer
Corporate governance
Business
Management

CORPORATE GOVERNANCE STATEMENT MULTIPLE SCLEROSIS LIMITED ABN[removed] A Company Limited by Guarantee Incorporated under the

Add to Reading List

Source URL: www.mssociety.org.au

Download Document from Source Website

File Size: 81,08 KB

Share Document on Facebook

Similar Documents

CAREER OPPORTUNITY Procurement Manager Reports To: Chief Financial Officer Salary Range: $51,248 – $79,343

CAREER OPPORTUNITY Procurement Manager Reports To: Chief Financial Officer Salary Range: $51,248 – $79,343

DocID: 1vfDu - View Document

Mike Saunter Global CFO Mike joined BBH in January 2015 as Global Chief Financial Officer, responsible for all aspects of the worldwide agency’s finances. Mike qualified as a Chartered Accountant at

Mike Saunter Global CFO Mike joined BBH in January 2015 as Global Chief Financial Officer, responsible for all aspects of the worldwide agency’s finances. Mike qualified as a Chartered Accountant at

DocID: 1vddR - View Document

Alumina Limited 2017 Full-Year Results Mike Ferraro, Chief Executive Officer Chris Thiris, Chief Financial Officer  Disclaimer

Alumina Limited 2017 Full-Year Results Mike Ferraro, Chief Executive Officer Chris Thiris, Chief Financial Officer Disclaimer

DocID: 1v5fY - View Document

Investor Contact: Ronald H. Spair Chief Financial Officer

Investor Contact: Ronald H. Spair Chief Financial Officer

DocID: 1v3Sx - View Document

ASX ANNOUNCEMENT 15 June 2015 Appointment of Chief Financial Officer Melbourne, Australia, 15 June 2015: Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”) is pleased to an

ASX ANNOUNCEMENT 15 June 2015 Appointment of Chief Financial Officer Melbourne, Australia, 15 June 2015: Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”) is pleased to an

DocID: 1uZTZ - View Document